Navigation Links
Human Primary Preadipocytes and Differentiated Adipocytes


Human Primary Preadipocytes and Differentiated Adipocytes

A new paradigm for energy metabolism research

Yuan-Di C. Halvorsen
Zen-Bio, Inc.

Peter Pingerelli Matt C. Petre
Stratagene

Regis Saladin
Ligand Pharmaceuticals

Michael R. Briggs
SmithKline Beecham Pharmaceuticals

Stratagene introduces new tools to facilitate the study of human adipocyte biology: Human Predifferentiated Adipocytes and Human Differentiated Adipocytes. Adipose tissue is a differentiated endocrine organ that primarily functions to manage energy homeostasis. Human primary adipocytes represent a model system to study these complex processes. The stromal-vascular fraction from adipose tissue can be processed to isolate preadipocytes and induced with hormones to differentiate into adipocytes. The resulting in vitro differentiated cells are functionally similar to primary human adipocytes and can be cultured for weeks without loss of adipocyte-specific markers, unlike the fragile primary adipocytes that die within 24 hours.

The study of adipocyte biology is important not only to understand metabolic diseases (including obesity, diabetes, dyslipidemia, and atherosclerosis), but to develop pharmacological agents to treat such maladies. Adipose tissue is critical for maintaining energy balance, because it serves both as a storage depot and an endocrine organ.1 It is actively involved in sensing the nutritional state of the organism through several different signaling pathways. It responds by altering the expression of genetic pathways to mobilize or store energy and activating signals to other tissues to regulate energy balance.

Previously, all research in adipocyte biology was conducted using rodent cells, mainly transformed cell lines.2 However, because humans and rodents have distinct genetic backgrounds and metabolic pathways, potential experimental pitfalls were inevitable. For example, compounds effective in activating the b3-adrenergic pathway in rodents failed to stimulate human adipocytes to burn more fat.3 Stratagene now offers Human Predifferentiated Adipocytes and Human Differentiated Adipocytes, so rodent systems can be bypassed for human systems in experiments involving adipocyte signal transduction pathways or gene regulation.

Human Preadipocyte Differentiation

When excess preadipocytes are recruited into the differentiated adipocyte, obesity results. Since from adolescence through adulthood humans continue to recruit cells to become adipocytes, it is of interest to study the environmental and humoral factors that initiate and maintain the differentiated phenotype of adipocytes. Human preadipocytes provide the tools to explore the most relevant factors that influence human obesity.

Stratagene recently developed the Adipocyte Differentiation Kit, which uses a simple and efficient method to differentiate human primary preadipocytes into mature, fully functional adipocytes. Undifferentiated preadipocytes are cultured in DMEM/F-10 (1:1, v/v) with 10% fetal bovine serum. The cells can be passaged for expansion, frozen for later reuse, or differentiated. The absence of staining with antisera to factor VIII and lack of vascular endothelial growth factor receptor mRNA, shown by Northern analysis, 4 demonstrated that no endothelial cells are present in the preadipocyte culture.

Earlier passage cells are more robust in both growth and differentiation potential; passages one to three are ideal. Stratagene uses only passage-two human preadipocytes for the Adipocyte Differentiation Kit. Typically, a production lot of cells is isogenic, and lots vary within the 10% to 20% range for total differentiation potential, as measured by lipid accumulation.

Up to 90% of the Human Predifferentiated Adipocytes can be induced to differentiate after they have been treated with a hormone and chemical cocktail. This treatment promotes a cascade of transcription factors activation and adipocyte-specific gene expression that leads to the mature adipocyte phenotype (Figure 1, panel A and B). Predifferentiated Adipocyte Differentiation Medium is also available from Stratagene as a separate reagent.

Figure 1

During the differentiation process5, key adipocyte- specific genes, such as PPARg, fatty acid binding protein, and obese gene, are expressed.6,7,8 Expression of signaling molecules, such as leptin, the obese gene product is induced during differentiation (Figure 2).

Figure 2

Practical Applications

By using Stratagenes Human Predifferentiated Adipocytes, various questions can be addressed: What makes these cells differentiate from fibroblast-like cells to adipocytes? What are adipocytes similarities and differences? What chemical and endocrine effectors transform preadipocytes? What gene expression changes are necessary and/or sufficient for preadipocyte transformation?

Human Predifferentiated Adipocytes are available in a 24- or 96-well format and are shipped ready to use. Besides providing a unique tool to study the processes that trigger and promote differentiation, these cells can be used to identify agents that block or slow the differentiation process.

Human Adipocyte-Specific Gene Expression

By characterizing gene expression and regulation, we may unravel the mysteries of the adipocytefrom its role as an endocrine receptor to its role as a mediator of energy homeostasis. Transfection experiments, which lead to overexpression of wild type or mutated protein forms, are used to characterize many gene functions. The phenotype of the altered expression state allows the effects of single gene changes to be examined, which may model metabolic derangement associated with particular diseases.9

To date we have successfully transfected Human Differentiated Adipocytes with the human adipose- specific obese gene and peroxisome proliferator activated receptor gamma (PPARg) gene promoter-driven reporters (data not shown). In experiments to improve the transfectability of Human Differentiated Adipocytes or Human Predifferentiated Adipocytes using Stratagenes Transfection MBS Mammalian Transfection Kit or LipoTAXI Transfection Reagent, respectively, we showed that including the Primary Transfection ENHANCER results in a higher transfection efficiency (Figure 3, panel A and panel B).

Figure 3

Lipolysis: A Differentiated Adipocyte Process

One of the key functions of adipocytes is to adjust lipid storage according to the physiological energy needs of the organism. When extra calories are required, adipocyte intracellular triglyceride stores are metabolized to glycerol and fatty acids for further oxidation, a process termed lipolysis.10 Our Human Differentiated Adipocytes respond to adrenergic hormone receptor agonists, such as norepinephrine or isoproterenol, to induce this metabolic pathway. The lipolysis response can be assayed by measuring the release of glycerol into the culture medium (Figure 4). Thus, these cells are useful for analyzing compounds or genes that induce, or are involved with, this important function of the mature adipocyte.

Figure 4

Conclusions

With Stratagenes new Human Predifferentiated Adipocytes and Human Differentiated Adipocytes, researchers have a new class of reagents with which to study human adipose biology. It is now possible to directly study the factors that affect human adipose differentiation, and to identify agents which may promote or interfere with the progression of obesity. Gene expression in both adipocytes and preadipocytes can be achieved with the aid of Primary Transfection ENHANCER, a new reagent developed by Stratagene to enhance primary cell transfection.

REFERENCES
  1. Flier, J. (1995) Cell 80: 15-18.

  2. Green, H. and Kehinde, O. (1975) Cell 5: 19-27.

  3. Arch, J.R.S. and Wilson, S. (1996) Int. J. Obes. 20: 191-199.

  4. Claffey, K. and Halvorsen, Y.C. unpublished results.

  5. Halvorsen, Y. C. unpublished results.

  6. Lehmann, J.M., et al. (1995) J. Clin. Invest. 270: 12953-12956.

  7. Tontonoz, P. Hu, E. and Spiegelman, B.M. (1994) Cell 79: 1147-1156.

  8. Brun, R.P., et al. (1996) Genes and Develop. 10: 974-984.

  9. Fraser, J.D., et al. (1997) J. Biol. Chem. 272: 13892-13898.

  10. Chernick, S., et al. (1986) J. of Lipid Res. 27: 286-294.


'"/>

Source:


Page: All 1 2 3 4 5 6

Related biology technology :

1. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
2. Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance
3. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
4. Human Universal cDNA Library Array I
5. Map and Link Human Genetic Disorders with SSLP Analysis
6. RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes
7. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
8. Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations
9. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
10. Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression Vector
11. Stratagenes Human cDNA Microarrays: Perform Gene Expression Profiling and Discover New Genes
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Human Primary Preadipocytes and Differentiated Adipocytes

(Date:2/26/2015)... 26, 2015 The Pittcon 2015 ... the Ernest N. Morial Convention Center in New ... of February 19, 2015) displaying products and services ... and government labs. The Exposition will offer the ... limited to, analytical chemistry; drug discovery; nanotechnology; life ...
(Date:2/26/2015)... NY (PRWEB) February 26, 2015 According ... Research ÔÇťAgricultural Biotechnology Market For Transgenic Crops (Corn, Soybean, ... Global Industry Analysis, Size, Share, Growth, Trends and Forecast, ... at USD 15,300 million in 2012 and is expected ... a CAGR of 9.5% from 2013 to 2019. ...
(Date:2/26/2015)... LOS ANGELES , Feb. 26, 2015 ... diversified life sciences company with interests in the natural ... platform technology, announced today that its products will be ... upcoming Roth Capital Partners, 27 th Annual Growth ... Ritz Carlton, located at 1 Ritz Carlton Drive, ...
(Date:2/26/2015)... , Feb. 26, 2015 CytomX, a ... cancer, today announced that Sean McCarthy , D. ... at the upcoming Cowen and Company 35 th ... . Dr. McCarthy,s presentation will take place at 4 ... CytomX Therapeutics CytomX Therapeutics develops Probody™ therapeutics for ...
Breaking Biology Technology:Pittcon 2015 Announces Exposition Highlights 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 3SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 2SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 3SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 4
... Nov. 20 Keck Graduate Institute (KGI) today ... Education for Women in the Life Science Industry" (NGBL) forum ... female CEOs of life science companies. , ... which specializes in the development of business leaders in bioscience, ...
... PARK, Calif., Nov. 20 MDV-Mohr Davidow Ventures, ... the addition of,Phyllis Whiteley and Dan Riskin to ... pursue and develop start-up,opportunities that provide healthcare providers ... wellness -- from prevention to diagnosis to the,treatment ...
... BANGALORE, India, November 20 ,Debiopharm Group ... focuses on serious medical conditions and ... (Aurigene), a,Bangalore-based fully integrated, global biotech ... discovery and development from target identification ...
Cached Biology Technology:KGI Announces Second Annual Executive Education Conference for Women in Life Sciences 2MDV Expands Team Pursuing Advances in Personalized Medicine 2Debiopharm and Aurigene Sign Licensing Agreement for the Development and Commercialisation of Debio 0617, a Novel Inhibitor of an Undisclosed Oncology Pathway 2Debiopharm and Aurigene Sign Licensing Agreement for the Development and Commercialisation of Debio 0617, a Novel Inhibitor of an Undisclosed Oncology Pathway 3
(Date:2/18/2015)... SUNNYVALE, Calif. , Feb. 18, 2015  Cepheid (NASDAQ: ... be speaking at the following conferences, and invited investors to ... Conference, Boston, MA Tuesday, March 3, ... Institutional Investors Conference, Orlando, FL Wednesday, ... Accessing Live Webcasts To access the live webcasts for these ...
(Date:2/12/2015)... Conn. , Feb. 12, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62/113114 for DISTRIBUTED ... DEVICES. The patent further establishes NXT-ID,s position ... its intellectual property portfolio the ability for multiple devices ...
(Date:2/9/2015)... RICHARDSON, Texas , Feb. 9, 2015  Lintec ... novel fabrication methods for carbon nanotube (CNT) macrostructures, including ... Texas at Dallas (UTD). Leveraging the vast ... Tokyo, Japan , Lintec of America ... Richardson, TX , focusing on scaling ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... Scientists at the Zucker Hillside Hospital campus of the ... markers that can increase a persons risk for schizophrenia. ... of the National Academy of Sciences, the research team ... be inherited in a recessive manner. A recessive trait ...
... have used ultraviolet light to sculpt three-dimensional microparticles ... and tissue engineering. For example, they could be ... molecules, such as DNA, or to release drugs ... control over the size, shape and texture of ...
... Journal of Lipid Research (Vol. 48, No. 12) ... Disease Increases Progression of Atherosclerosis, Breaking the Vicious Cycle ... Genetic Variants Affect Weight-Associated Cholesterol Metabolism ... alter how the body adjusts cholesterol metabolism in response ...
Cached Biology News:Feinstein researchers develop new genetic method and identify novel genes for schizophrenia 2MIT sculpts 3-D particles with light 2Story ideas from the Journal of Lipid Research 2Story ideas from the Journal of Lipid Research 3
Recombinant Viral CCI/Fc Chimera, CF...
... • Guinea Pig serum is collected from fasted ... N-02: Citrate N-04: Heparin (Na) ... Oxalate N-10: EDTA (Na) N-03: ... CPD N-09: K3EDTA N-11: ...
GENOMIPHI V2 DNA AMP KIT 25RXN, 1 EA. Category: Genomics DNA Amplification....
EPH electrode, anode, 1. Category: Electrophoresis Systems & Standards & Reagents, IEF & SDS-PAGE & 2-D Electrophoresis, Multiphor II Kits & Components and Accessories....
Biology Products: